Uterine fibroids — why you should choose tailored therapies based on the joint decision of the physician and the patient
Uterine fibroids (UFs) are the most common benign tumors of the myometrium, affecting up to 70% women by age 50. Although many cases remain asymptomatic, symptomatic UFs can significantly reduce quality of life through excessive bleeding, anemia, pelvic pain, infertility, and obstetric complications...
Saved in:
| Main Authors: | Michal Ciebiera, Tomasz Lozinski, Ayman Al-Hendy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Via Medica
2025-07-01
|
| Series: | Ginekologia Polska |
| Subjects: | |
| Online Access: | https://journals.viamedica.pl/ginekologia_polska/article/view/107627 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tailoring the Diagnostic Pathway for Medical and Surgical Treatment of Uterine Fibroids: A Narrative Review
by: Gabriele Centini, et al.
Published: (2024-09-01) -
High-intensity focused ultrasound treatment for large and small solitary uterine fibroids
by: Chih-Ting Chang, et al.
Published: (2022-12-01) -
The Hemodynamic Stability of Dexmedetomidine during Laparoscopic Uterine Fibroids Surgery: A Randomized Controlled Study
by: Xia Cao, et al.
Published: (2024-05-01) -
Uterine fibroids and infertility: a controverse but concrete link
by: Radmila Sparić, et al.
Published: (2022-01-01) -
The possible association of uterine fibroid formation with copper intrauterine device use: a cross-sectional study
by: Sevcan Arzu Arinkan, et al.
Published: (2021-08-01)